Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sopharma AD Capital/Financing Update 2023

Oct 6, 2023

2543_rns_2023-10-06_227e9316-76f1-476f-a837-76326c8aa0d3.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Current report №183/2023 Dated October 6, 2023

NOTIFICATION

"Sopharma" AD (the Company) notifies that as a result of the conditional capital increase through the exercise of warrants from an issue with ISIN BG9200001212 the new capital of "Sopharma" AD amounting to BGN 172,590,578 was entered in the Commercial Register, under number 20231006154857.

A procedure for registration of the new issue in the registers of the Financial Supervision Commission and "Central Depository" AD and the admission of the shares from the increase to trading on "Bulgarian Stock Exchange" AD is pending.

Ognian Donev